4.7 Article

The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study

Journal

CLINICAL INFECTIOUS DISEASES
Volume 73, Issue 3, Pages 487-496

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciaa653

Keywords

antimicrobial stewardship; antibiotic allergy; penicillin allergy; oral challenge; direct provocation

Funding

  1. Better Care Victoria Innovation Fund, Better Care Victoria, Victoria Department of Health, Australia
  2. National Health and Medical Research Council (NHMRC) Early Career Research Grant [GNT 1139902]
  3. Royal Australasian College of Physicians (RACP) Research Establishment Fellowship
  4. National Centre for Infections in Cancer (NCIC)
  5. National Institutes of Health [1P50GM115305-01, R21AI139021, R34AI136815, 1 R01 HG010863-01]
  6. National Health and Medical Research Council of Australia

Ask authors/readers for more resources

This study showed that the program of inpatient delabeling for low-risk penicillin allergies using a combination of direct delabeling and oral penicillin challenge led to increased usage of narrow-spectrum penicillins, improved appropriate antibiotic prescribing, and reduced usage of restricted antibiotics.
Background. Penicillin allergies are associated with inferior patient and antimicrobial stewardship outcomes. We implemented a whole-of-hospital program to assess the efficacy of inpatient delabeling for low-risk penicillin allergies in hospitalized inpatients. Methods. Patients >= 18 years of age with a low-risk penicillin allergy were offered a single-dose oral penicillin challenge or direct label removal based on history (direct delabeling). The primary endpoint was the proportion of patients delabeled. Key secondary endpoints were antibiotic utilization pre- (index admission) and post-delabeling (index admission and 90 days). Results. Between 21 January 2019 and 31 August 2019, we assessed 1791 patients reporting 2315 antibiotic allergies, 1225 with a penicillin allergy. Three hundred fifty-five patients were delabeled: 161 by direct delabeling and 194 via oral penicillin challenge. Ninety-seven percent (194/200) of patients were negative upon oral penicillin challenge. In the delabeled patients, we observed an increase in narrow-spectrum penicillin usage (adjusted odds ratio [OR], 10.51 [95% confidence interval {CI}, 5.39-20.48]), improved appropriate antibiotic prescribing (adjusted OR, 2.13 [95% CI, 1.45-3.13]), and a reduction in restricted antibiotic usage (adjusted OR, 0.38 [95% CI, .27-.54]). In the propensity score analysis, there was an increase in narrow-spectrum penicillins (OR, 10.89 [95% CI, 5.09-23.31]) and beta-lactam/beta-lactamase inhibitors (OR, 6.68 [95% CI, 3.94-11.35]) and a reduction in restricted antibiotic use (OR, 0.52 [95% CI, .36-.74]) and inappropriate prescriptions (relative risk ratio, 0.43 [95% CI, .26-.72]) in the delabeled group compared with the group who retained their allergy label. Conclusions. This health services program using a combination of direct delabeling and oral penicillin challenge resulted in significant impacts on the use of preferred antibiotics and appropriate prescribing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available